These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 37982935

  • 1. Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life.
    Traykov V, Shalganov T.
    Curr Cardiol Rep; 2023 Dec; 25(12):1839-1849. PubMed ID: 37982935
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P, Viveros D, Falasconi G, Penela D, Soto-Iglesias D, Martí-Almor J, Alderete J, Saglietto A, Bellido AF, Franco-Ocaña P, Zaraket F, Matiello M, Fernández-Armenta J, San Antonio R, Berruezo A.
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [Abstract] [Full Text] [Related]

  • 3. Cardioneuroablation for Treating Vasovagal Syncope: Current Status and Future Directions.
    Li L, Po S, Yao Y.
    Arrhythm Electrophysiol Rev; 2023 Sep; 12():e18. PubMed ID: 37457436
    [Abstract] [Full Text] [Related]

  • 4. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R, Baran J, Sikorska A, Krynski T, Kulakowski P.
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [Abstract] [Full Text] [Related]

  • 5. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study.
    Aksu T, Guler TE, Mutluer FO, Bozyel S, Golcuk SE, Yalin K.
    J Interv Card Electrophysiol; 2019 Mar; 54(2):177-188. PubMed ID: 30054828
    [Abstract] [Full Text] [Related]

  • 6. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B, Morillo CA, Sheldon RS, Chew DS, Aksu T, Raj SR.
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [Abstract] [Full Text] [Related]

  • 7. Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials.
    Chakraborty P, Chen PS, Gollob MH, Olshansky B, Po SS.
    Heart Rhythm; 2024 Apr; 21(4):464-470. PubMed ID: 38104955
    [Abstract] [Full Text] [Related]

  • 8. Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.
    Penela D, Berruezo A, Roten L, Futyma P, Richter S, Falasconi G, Providencia R, Chun J.
    Europace; 2024 May 02; 26(5):. PubMed ID: 38781099
    [Abstract] [Full Text] [Related]

  • 9. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.
    Aksu T, Tung R, De Potter T, Markman TM, Santangeli P, du Fay de Lavallaz J, Winterfield JR, Baykaner T, Alyesh D, Joza JE, Gopinathannair R, Badertscher P, Do DH, Hussein A, Osorio J, Dewland T, Perino A, Rodgers AJ, DeSimone C, Alfie A, Atwater BD, Singh D, Kumar K, Salcedo J, Bradfield JS, Upadhyay G, Sood N, Sharma PS, Gautam S, Kumar V, Forno ARJD, Woods CE, Rav-Acha M, Valeriano C, Kapur S, Enriquez A, Sundaram S, Glikson M, Gerstenfeld E, Piccini J, Tzou WS, Sauer W, d'Avila A, Shivkumar K, Huang HD.
    J Interv Card Electrophysiol; 2024 Mar 18. PubMed ID: 38499825
    [Abstract] [Full Text] [Related]

  • 10. Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analysis.
    Armani Prata A, Katsuyama E, Scardini P, Antunes V, Granja J, Coan AC, Fukunaga C, Pachón Mateos JC.
    Heart Rhythm; 2024 Jul 25. PubMed ID: 39067734
    [Abstract] [Full Text] [Related]

  • 11. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T, Chung MK.
    Curr Cardiovasc Risk Rep; 2024 Apr 25; 18(4):55-64. PubMed ID: 38707611
    [Abstract] [Full Text] [Related]

  • 12. Management strategies for vasovagal syncope.
    Ali M, Pachon Maetos JC, Kichloo A, Masudi S, Grubb BP, Kanjwal K.
    Pacing Clin Electrophysiol; 2021 Dec 25; 44(12):2100-2108. PubMed ID: 34748224
    [Abstract] [Full Text] [Related]

  • 13. Cardioneuroablation for cardioinhibitory vasovagal syncope.
    John LA, Mullis A, Payne J, Tung R, Aksu T, Winterfield JR.
    J Cardiovasc Electrophysiol; 2021 Jun 25; 32(6):1748-1753. PubMed ID: 33855779
    [Abstract] [Full Text] [Related]

  • 14. Endocardial ablation of epicardial ganglionated plexi: history, open questions and future prospects of cardioneuroablation.
    Magnano M, Bissolino A, Budano C, Occhetta E, Rametta F.
    Minerva Cardiol Angiol; 2023 Oct 25; 71(5):553-563. PubMed ID: 36305776
    [Abstract] [Full Text] [Related]

  • 15. Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis.
    Vandenberk B, Lei LY, Ballantyne B, Vickers D, Liang Z, Sheldon RS, Chew DS, Aksu T, Raj SR, Morillo CA.
    Heart Rhythm; 2022 Nov 25; 19(11):1804-1812. PubMed ID: 35716859
    [Abstract] [Full Text] [Related]

  • 16. Cardioneuroablation in the Management of Vasovagal Syncope, Sinus Node Dysfunction and Functional Atrioventricular Block: Patient Selection Based on Supporting Evidence.
    Aksu T, Erdem Guler T.
    J Atr Fibrillation; 2020 Nov 25; 13(1):2396. PubMed ID: 33024497
    [Abstract] [Full Text] [Related]

  • 17. Right anterior ganglionated plexus: The primary target of cardioneuroablation?
    Hu F, Zheng L, Liang E, Ding L, Wu L, Chen G, Fan X, Yao Y.
    Heart Rhythm; 2019 Oct 25; 16(10):1545-1551. PubMed ID: 31330187
    [Abstract] [Full Text] [Related]

  • 18. Selective vagal innervation principles of ganglionated plexi: step-by-step cardioneuroablation in a patient with vasovagal syncope.
    Aksu T, Guler TE, Bozyel S, Yalin K.
    J Interv Card Electrophysiol; 2021 Apr 25; 60(3):453-458. PubMed ID: 32394104
    [Abstract] [Full Text] [Related]

  • 19. Cardioneuroablation for severe neurocardiogenic syncope.
    Santos Silva G, Fonseca P, Cardoso F, Almeida J, Ribeiro S, Oliveira M, Sanfins V, Gonçalves H, Pachon M JC, Barra S, Primo J, Lourenço A, Fontes-Carvalho R.
    Rev Port Cardiol; 2023 Oct 25; 42(10):821-829. PubMed ID: 37268266
    [Abstract] [Full Text] [Related]

  • 20. Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.
    Tu B, Wu L, Hu F, Fan S, Liu S, Liu L, Ding L, Zheng L, Yao Y.
    Heart Rhythm; 2022 Apr 25; 19(4):562-569. PubMed ID: 34896621
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.